drugset
drugset / Trial / NCT02844790

A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects

NCT02844790 ↗

Phase 1 Completed 24 enrolled Novo Nordisk A/S
NaSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Asia. The aim of this trial is to investigate the pharmacokinetic (the exposure of the trial drug in the body) properties of insulin degludec/insulin aspart in healthy Chinese subjects.

Timeline

Start
2016-07-26
Primary completion
2016-09-26
Completion
2016-09-27

Publications

  • Background Aixin S, Yang L, Panpan X, Qi W , Lei Y, Hongfei X, Ran LZ, Haahr H. A study investigating the pharmacokinetic properties of insulin degludec/insulin aspart in healthy Chinese subjects. Diabetes Manag. 2019; 9 (2): 48-56.

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin degludec/insulin aspart Unknown — Subcutaneous

Indications

No indication recorded.